Cargando…
Minimally invasive local therapies for liver cancer
Primary and metastatic liver tumors are an increasing global health problem, with hepatocellular carcinoma (HCC) now being the third leading cause of cancer-related mortality worldwide. Systemic treatment options for HCC remain limited, with Sorafenib as the only prospectively validated agent shown...
Autores principales: | Li, David, Kang, Josephine, Golas, Benjamin J., Yeung, Vincent W., Madoff, David C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chinese Anti-Cancer Association
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4296086/ https://www.ncbi.nlm.nih.gov/pubmed/25610708 http://dx.doi.org/10.7497/j.issn.2095-3941.2014.04.001 |
Ejemplares similares
-
Minimally Invasive Ablative Therapies for Definitive Treatment of Localized Prostate Cancer in the Primary Setting
por: Lee, Eugene W., et al.
Publicado: (2011) -
Recent Advances in Minimally Invasive Liver Resection for Colorectal Cancer Liver Metastases—A Review
por: Lo, Winifred M., et al.
Publicado: (2022) -
Minimally Invasive Local Treatments for Bone and Pulmonary Metastases
por: Bedi, Meena, et al.
Publicado: (2014) -
Current status of minimally invasive liver surgery for cancers
por: Morise, Zenichi
Publicado: (2022) -
Minimally Invasive Approaches for Surgical Management of Primary
Liver Cancers
por: Beard, Rachel E., et al.
Publicado: (2017)